Prevalence and Incidence of Cervical Cancer

Cervical Cancer:

Cervical Cancer is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Cervical Cancer, or a subtype of Cervical Cancer, affects less than 200,000 people in the US population.

Incidence (annual) of Cervical Cancer:

13,000 annual cases in USA (SEER 2002 estimate)

Incidence Rate:

approx 1 in 20,923 or 0.00% or 13,000 people in USA [about data]

Incidence extrapolations for USA for Cervical Cancer:

13,000 per year, 1,083 per month, 250 per week, 35 per day, 1 per hour, 0 per minute, 0 per second.

Lifetime risk for Cervical Cancer:

1 in 117 lifetime risk for women in the US (Cancer Facts and Figures, American Cancer Society, 2004)

Prevalance of Cervical Cancer:

The American Cancer Society estimated that about 12,800 women in the United States were diagnosed with invasive cervical cancer in 2000. (Source: excerpt from HPV: DSTD)

Prevalence/Incidence of Cervical Cancer: Online Medical Books

16 MEDICAL BOOKS ONLINE! Review excerpts from medical books online, free, without registration, for more information about the prevalence and/or incidence of Cervical Cancer.

Cervical cancer: Causes and incidence
(Professional Guide to Diseases (Eighth Edition))

Although the cause is unknown, several predisposing factors have been related to the development of cervical cancer: frequent intercourse at a young age (younger than age 16), multiple sexual partners, multiple pregnancies, exposure to sexually transmitted diseases (particularly genital human papillomavirus), and smoking.

In almost all cases of cervical cancer (95%), the histologic type is squamous cell cancer, which varies from well-differentiated cells to highly anaplastic spindle cells. Only 5% are adenocarcinomas. Usually, invasive cancer occurs between ages 30 and 50; rarely, in patients younger than age 20.

In 2000, 12,800 women were diagnosed with cervical cancer and there were 4,600 deaths from this disease.

READ BOOK EXCERPT ONLINE »

Malignant spinal neoplasms: Causes and incidence
(Professional Guide to Diseases (Eighth Edition))

Primary tumors of the spinal cord may be extramedullary (occurring outside the spinal cord) or intramedullary (occurring within the cord itself). Extramedullary tumors may be intradural (meningiomas and schwannomas), which account for 60% of all primary malignant spinal cord neoplasms, or extradural (metastatic tumors from breasts, lungs, prostate, leukemia, or lymphomas), which account for 25% of these malignant neoplasms.

Intramedullary tumors, or gliomas (astrocytomas or ependymomas), are comparatively rare, accounting for only about 10%. In children, they're low-grade astrocytomas.

Spinal cord tumors are rare compared with intracranial tumors (ratio of 1:4). They occur equally in men and women, with the exception of meningiomas, which occur mostly in women. Spinal cord tumors can occur anywhere along the length of the cord or its roots.

READ BOOK EXCERPT ONLINE »

Uterine cancer: Causes and incidence
(Professional Guide to Diseases (Eighth Edition))

Uterine cancer seems linked to several predisposing factors:

❑abnormal uterine bleeding

❑diabetes

❑familial tendency

❑history of uterine polyps or endometrial hyperplasia

❑hypertension

❑low fertility index and anovulation

❑nulliparity

❑obesity

❑uninterrupted estrogen stimulation.

In most cases, uterine cancer is an adenocarcinoma that metastasizes late, usually from the endometrium to the cervix, ovaries, fallopian tubes, and other peritoneal structures. It may spread to distant organs, such as the lungs and the brain, through the blood or the lymphatic system. Lymph node involvement can also occur. Less common are adenoacanthoma, endometrial stromal sarcoma, lymphosarcoma, mixed mesodermal tumors (including carcinosarcoma), and leiomyosarcoma.

Uterine cancer usually affects postmenopausal women between ages 50 and 60; it's uncommon between ages 30 and 40 and extremely rare before age 30. Most premenopausal women who develop uterine cancer have a history of anovulatory menstrual cycles or other hormonal imbalance. About 37,000 new cases of uterine cancer are reported annually, with approximately 6,400 deaths predicted for 1999.

READ BOOK EXCERPT ONLINE »

Incidence of Cervical Cancer:

An estimated 13,700 cases of invasive cervical cancer will be diagnosed in the United States in 1998. (Source: excerpt from Sexually Transmitted Diseases Statistics, NIAID Fact Sheet: NIAID)

Incidence statistics for Cervical Cancer:

The following statistics relate to the incidence of Cervical Cancer:

• 10,520 new cases for cervix cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
• 10,520 new female cases for cervix cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
• Estimated 13,000 new cases in women in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
• Cervix cancer incidence statistics by racial groups in the USA:
  • 9.2 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 12.4 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 10.2 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 6.9 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 16.8 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
• Cervical cancer incidence rates in various countries:
  • 29.8 women per 100,000 population with cervical cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 17.1 women per 100,000 population with cervical cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 16.1 women per 100,000 population with cervical cancer in the Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 14.4 women per 100,000 population with cervical cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 13.9 women per 100,000 population with cervical cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 12.7 women per 100,000 population with cervical cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 12.3 women per 100,000 population with cervical cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 8.2 women per 100,000 population with cervical cancer in the UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 7.7 women per 100,000 population with cervical cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 7.4 women per 100,000 population with cervical cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 7.3 women per 100,000 population with cervical cancer in Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 7.1 women per 100,000 population with cervical cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
• 1,350 new cases of cervical cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
• 8 per 100,000 new cases of cervical cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
• Cervical cancer incidence rates in various countries:
  • 14.2 new cases per 100,000 population for cervical cancer in Argentina 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 22.1 new cases per 100,000 population for cervical cancer in Bahamas 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 30.4 new cases per 100,000 population for cervical cancer in Barbados 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 39.6 new cases per 100,000 population for cervical cancer in Belize 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 58.1 new cases per 100,000 population for cervical cancer in Bolivia 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 31.3 new cases per 100,000 population for cervical cancer in Brazil 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 8.2 new cases per 100,000 population for cervical cancer in Canada 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 29.2 new cases per 100,000 population for cervical cancer in Chile 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 32.9 new cases per 100,000 population for cervical cancer in Colombia 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 25 new cases per 100,000 population for cervical cancer in Costa Rica 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 23.8 new cases per 100,000 population for cervical cancer in Cuba 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 38.4 new cases per 100,000 population for cervical cancer in Dominican Republic 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 44.2 new cases per 100,000 population for cervical cancer in Ecuador 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 40.6 new cases per 100,000 population for cervical cancer in El Salvador 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 39.6 new cases per 100,000 population for cervical cancer in Guatemala 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 51.1 new cases per 100,000 population for cervical cancer in Guyana 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 93.9 new cases per 100,000 population for cervical cancer in Haiti 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 39.6 new cases per 100,000 population for cervical cancer in Honduras 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 43.4 new cases per 100,000 population for cervical cancer in Jamaica 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 40.5 new cases per 100,000 population for cervical cancer in Mexico 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 61.1 new cases per 100,000 population for cervical cancer in Nicaragua 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 31.2 new cases per 100,000 population for cervical cancer in Panama 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 41.1 new cases per 100,000 population for cervical cancer in Paraguay 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 39.9 new cases per 100,000 population for cervical cancer in Peru 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 10.3 new cases per 100,000 population for cervical cancer in Puerto Rico 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 43.8 new cases per 100,000 population for cervical cancer in Suriname 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 33.3 new cases per 100,000 population for cervical cancer in Trinidad and Tobago 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 7.8 new cases per 100,000 population for cervical cancer in the US 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 13.8 new cases per 100,000 population for cervical cancer in Uruguay 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
  • 38.3 new cases per 100,000 population for cervical cancer in Venezuela 2000 (Regional Core Health Data Initiative, Pan American Health Organisation, 2003)
• 10 new female cases of cervical cancer per 100,000 population aged 20-74 in Australia 2000 (Australia’s Health 2004, AIHW)
• Incidence statistics by state in Australia:
  • 9.1 new female cases of cervical cancer occurred per 100,000 population in New South Wales 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • 7.9 new female cases of cervical cancer occurred per 100,000 population in Victoria 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • 10 new female cases of cervical cancer occurred per 100,000 population in Queensland 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • 8.5 new female cases of cervical cancer occurred per 100,000 population in Western Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • 6.8 new female cases of cervical cancer occurred per 100,000 population in South Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • 9.5 new female cases of cervical cancer occurred per 100,000 population in Tasmania 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • 7.3 new female cases of cervical cancer occurred per 100,000 population in Australian Capital Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • 15.9 new female cases of cervical cancer occurred per 100,000 population in Northern Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)

About prevalence and incidence statistics:

The term 'prevalence' of Cervical Cancer usually refers to the estimated population of people who are managing Cervical Cancer at any given time. The term 'incidence' of Cervical Cancer refers to the annual diagnosis rate, or the number of new cases of Cervical Cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.